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1. Introduction 
Kidney transplantation requires the availability of allografts obtained from diverse types of 
donors. Once the kidney is outside of the donor's body, it must be preserved in a state in 
which, after being transplanted, its normal operation can be quickly restored. Proper 
preservation of the renal graft is crucial, because it extends the viability of the organ, thus 
providing time for the complex preparation steps that are required for the transplantation 
procedure. These preparatory steps include the selection of the recipient, histocompatibility 
testing, transportation of the organ over long distances, and preparation of the recipient in 
the operating room.  
The first documented case of perfusion and preservation of an isolated organ was 
performed by Loebel in 1849. Other pioneers have subsequently contributed to this area: 
Langendorf in 1845 used a siphoning tube connected to the organ, while Martin created a 
method to perfuse the coronary artery in vitro in the early 1900’s. In 1905 Carrel published 
“Anastomosis and Transplant of Blood Vessels”. Around 1930, Heinz Rosenberg built a 
perfusion machine, and in 1935 Lindbergh built a pulsatory perfusion machine. 
In the early 1960’s, the only known preservation method was simple organ cooling. 
Lapchinsky in the former Soviet Union started transplanting extremities and kidneys that 
were preserved at +2°C and +4°C, preserving them for up to 28 hours. In 1963 Calne and 
Pegg demonstrated that perfusion of cold blood to an ischemic kidney could prolong its 
preservation up to 12 hours. In 1967, Belzer preserved kidneys for up to 72 hours, using a 
method of continuous perfusion “ex situ”. In 1969 Collins described the use of a preservation 
solution that resembled the composition of the intracellular fluid, and was used for 
perfusion/rinsing of the organ in cold temperature “in situ”, and also for its further 
hypothermic storage, achieving kidney preservation for up to 30 hours. In the 1980’s Belzer, 
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Southard and many other investigators started to lay the foundations for understanding the 
metabolic changes that occur in the extracted organs after explantation. 
In this chapter the techniques for kidney allograft preservation will be briefly reviewed, and 
the pathophysiological changes that occur during preservation and reperfusion of the 
allograft will be discussed. Finally, the currently used preservation solutions will be 
described. 
2. Techniques for preservation of the renal allograft 
2.1 Hypothermic perfusion techniques 
The combination of continuous perfusion and hypothermic storage used by Belzer et al. in 
1967 represented a new paradigm in regards to organ preservation, achieving successful 
canine kidney preservation for 72 hours. In this technique, after the initial washes 
performed during perfusion in the operating room, the organ is introduced in a device that 
keeps a controlled flow (continuous or pulsatory) with cold preservation solution (0-4°C). 
This flow allows complete perfusion of the organ and clearing of any micro thrombi in the 
blood stream, while facilitating the elimination of final metabolic products. Its beneficial 
effects include a lower incidence of delay in the initial functioning of the graft, the 
possibility to assess its viability in real time, and the possibility of providing metabolic 
(oxygen or substrates) or pharmacologic support during the perfusion. The hypothermic 
perfusion machine (HPM) with continuous flow has not shown advantages with respect to 
the pulsatory flow machine. Figures; 1 and 2, shows some of the perfusion machines 
currently being used. 
 
Fig. 1. Hypothermic perfusion machine: Waters RM3® Renal Preservation System from 
Waters Medical System®.  
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Fig. 2. Hypothermic perfusion machine: Life Port Kidney Transporter® from Organ 
Recovery Systems®. 
To date, hypothermic perfusion is the approach that provides the longest possible 
preservation time for renal allografts. However, due to its complexity, high cost, and the 
need for abundant equipment, these techniques are only suitable for use in facilities highly 
specialized in renal preservation. Additionally, they require well prepared personnel with 
vast experience in the field of allograft preservation. 
The use of HPM has the following advantages and disadvantages: 
Advantages: 
1. Less incidence of delay in the re-initiation of kidney allograft function. 
2. Better preservation for longer periods of time (especially greater than 24 hours) 
3. Ability to control flow and pressure, therefore ability to monitor intrarenal resistance 
during perfusion. 
4. Decreased renal vasospasm. 
5. Ability to provide metabolic support during perfusion. 
6. Potential for pharmacological manipulation during perfusion. 
Disadvantages: 
1. Increased cost. 
2. Endothelial injury. 
3. Possibility of mechanical failure. 
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2.2 Normothermic preservation techniques 
Just recently, interest has been arising on the beneficial effects of continuous normothermic 
or subnormothermic perfusion (25-37 °C) in the preservation process, especially of kidneys 
from non-beating heart donors. The potential benefits of normothermia during perfusion are 
the decrease of vascular resistance and the increase in oxygen release. 
2.3 Oxygen insufflation technique 
This technique was first described by Isselhard et al. in 1972, in which oxygen is insufflated 
through the kidney vessels and then escapes through small perforations on the organ’s 
surface. This technique was attempted for the first time in canine kidneys, and has been the 
subject of a pilot clinical study. 
2.4 Preservation by cold storage  
This technique consists in substituting the vascular contents for a cold preservation solution, 
replacing the intracellular fluid for that of the solution. It is a very simple technique, but it 
only partially achieves its objective, because, in contrast to the continuous perfusion 
techniques, it does not maintain cellular metabolism in hypothermia. This is the technique 
that the majority of renal explantation teams utilize. The following is required for its 
application: 
1. Preservation solution. 
2. The temperature of the preservation solution should be 4°C. 
3. The perfusion fluid should be infused at a pressure greater than 60 torr, ensuring the 
complete elimination of the graft’s vascular contents. In practice, this is achieved by 
placing the perfusion fluids at 100-150 cm above the organs to be perfused. 
4. The amount of solution necessary to preserve the kidney is 1 liter, but it is standard 
practice to stop perfusion only after the effluent fluid from the graft does not contain 
any blood. 
3. Pathophysiology and basis for the preservation of a renal allograft 
The extraction, storage, and transplantation of a renal allograft from a donor significantly 
alter the kidney’s internal homeostasis. The extent of these changes influences the extent to 
which kidney function will be recovered after transplantation. Kidney injury mainly occurs 
as a result of ischemia, and the different preservation techniques serve to minimize this 
injury and improve the allograft’s function and survival. 
3.1 Basis for the preservation of the renal allograft 
Any kidney that has been extracted from the body suffers a process known as ischemia. The 
graft does not receive oxygen or nutritional support, and at the same time, products of its 
own metabolism accumulate, resulting in injury. The injury to the tissue is initially 
reversible, but after a certain interval it becomes irreversible. This phenomenon is known as 
“hot ischemia”, and under these conditions the time limit for organ viability is between 30 
and 60 minutes. 
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The deterioration caused by ischemia is mediated by chemical reactions that happen more 
or less rapidly depending on the temperature. During hypothermia, reversible ischemic 
injury also appears early on (“cold ischemia”), but differs from hot ischemia in several ways. 
The fundamental cause of ischemic injury resides in the molecular changes suffered by 
cellular membranes. Initially, the cells swell and become turgid due to the alterations in the 
functionality of the cell membrane. After 60 minutes of hot ischemia, rupture of renal cell 
membranes is observed, followed by cellular necrosis. 
Another phenomenon also observed in hot ischemia is called “absence of reflux”, which 
comprises the lack of blood flow when circulation is restored to the organ. This occurs when 
erythrocytes accumulate in the vessels. Therefore, completely eliminating erythrocytes in 
the vessels through rinsing during the ischemic period is essential. 
3.2 Effects of hypothermia (cold ischemia) 
The key to successful organ preservation is hypothermia. Cooling reduces the rate at which 
intracellular enzymes degrade the components that are essential for cellular viability. 
Hypothermia does not completely stop cellular metabolism, it only slows it down for a 
limited time, after which function ceases completely and viability is lost (cellular death). The 
length of this period is organ-specific. 
The majority of enzymes in normothermic animal cells show a decrease in their activity 
from 1.5- 2 times for each 10°C decrease in temperature, following the Van Hoff rule: 
Q10= (K₂/K1)10/(t2-t1) 
Where Q10 is the coefficient for a change of 10°C in temperature, and K1 and K₂ are the rates 
of the enzymatic reactions at temperatures t1 and t2, respectively. In a renal cell with a Q10 of 
2, a change in temperature from 37°C to 0°C decreases the rate of the metabolic reactions by 
a factor of 12 to 13. 
The majority of organs tolerate between 30 to 60 minutes of hot ischemia, without 
completely losing their function. Thus, the simple cooling of a kidney increases its 
preservation time up to 12 to 13 hours, as shown by Calne and Pegg in 1963. After 13 hours, 
ultrastructural changes can be observed in the proximal tubules and, to a lesser extent, in the 
distal tubules. 
The only methods that could in theory maintain a kidney viable for months or years are 
freezing of the organ, or its continuous aerobic perfusion. Temperatures below 0°C have 
been used to successfully preserve isolated cells and some simple tissues, but not kidneys. 
Cryopreservation is still an exciting and complex field of research. The method of 
continuous aerobic perfusion is complex, expensive and requires trained personnel with 
vast experience in organ preservation, and thus this technique is not routinely used in 
clinical practice. 
The ideal preservation temperature for kidney allografts is between 0°C and 5°C (4°C seems 
to be the ideal temperature). Higher temperatures would accelerate cellular metabolism, 
making it necessary to provide nutrients to support its metabolic requirements through 
continuous perfusion during the preservation period. 
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As previously mentioned, in cold ischemia, besides hypothermia, perfusion fluids are also 
needed. Therefore, the renal allograft is subjected to ischemia in anaerobic hypothermia, 
which is accompanied by the events described below. 
3.2.1 Cellular edema induced by ischemia and hypothermia 
Under normal conditions, the cells are in an extracellular environment rich in sodium and 
low in potassium, while the intracellular environment is poor in sodium and rich in 
potassium. This equilibrium against a gradient between both sides of the plasma membrane 
is maintained by the Na+/K+ pump which requires energy (ATP) obtained from oxidative 
phosphorylation. The pump keeps this balance by avoiding the entrance of sodium into the 
cell and counteracting the colloidal osmotic pressure derived from proteins and other 
intracellular anions. Under normal conditions, the intracellular osmotic force is 110-140 
mOsm/Kg. 
Anaerobic hypothermia (such as in the kidney stored in the cold) decreases the activity of 
the Na+/K+ pump and reduces the plasma membrane potential.  Sodium and chloride enter 
the cell following a concentration gradient, dragging with them water, which causes the cell 
to swell, causing cellular edema (Fig 3). This edema could be counteracted by adding to the 
preservation solution 110-140 mmol/l of substances that are impermeable to the cell (i.e. 
they cannot pass the plasma membrane due to their elevated molecular weight). We will 
refer to these substances as “waterproofing agents”. 
 
Fig. 3. Cellular edema. 
The problem posed by waterproofing agents is that, even though they diffuse poorly across 
the membrane, they will eventually enter the cell over time. Therefore, when implanting the 
kidney in its new environment, the cells will suddenly be exposed to a relatively hypotonic 
extracellular osmolarity. Because the Na+/K+ pump is unable to start functioning quickly 
enough, potassium cannot be easily expelled to counteract this effect. One example of such 
agents is mannitol, which can be used as a waterproofing agent in preservation solutions. 
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Mannitol accumulates intracellularly, cannot be metabolized, and is only slowly eliminated 
from the cytosol, leading to cellular edema not directly related to hypothermia. Edema in 
endothelial cells can interfere with the reestablishment of normal blood flow, which by itself 
results in hot ischemia.  Edema of parenchymal cells will also involve the mitochondria, 
with subsequent structural and functional deterioration of the tissue. The majority of 
preservation solutions contain waterproofing agents at a concentration close to 110 mmol/l. 
It seems that obtaining an adequate concentration of waterproofing agents in these solutions 
is essential to achieve adequate preservation by storage in cold. 
3.2.2 Cellular acidosis 
The cells of the organs stored in cold are under anaerobic conditions. To maintain their 
energy needs (ATP), they use anaerobic glycolysis which increases the concentration of 
lactate and hydrogen ions intracellularly. This causes acidosis that leads to lysosomal 
instability, activates lysosomal enzymes, and alters mitochondrial properties, which causes 
cell injury and death. (Fig 4). 
 
Fig. 4. Glycolysis. 
To prevent intracellular acidosis, preservation solutions that contain substances that 
counteract acidosis (buffers) are used.  Substances such as phosphate or histidine are used 
for this purpose.  On the other hand, it seems advisable to have a slightly alkaline pH (7.6 – 
8.0 at 37°C) in the solution destined for cold rinsing. 
3.2.3 Expansion of the interstitial space  
When an organ is perfused, and also later during its storage, there is an expansion of the 
interstitial space. This compresses the capillary system, causing the inadequate distribution 
of the preservation fluid across the tissue. Solutions that do not contain oncotic substances 
(such as albumin and other colloids) quickly diffuse to the interstitial space and cause 
edema when perfused. The preservation solution needs to contain substances that will 
create enough osmotic colloidal pressure to allow the free exchange of essential substances 
with the preserving solution, without expanding the interstitial space (Fig 5).  
www.intechopen.com
 
Renal Transplantation – Updates and Advances 
 
8 
 
Fig. 5. Osmotic colloidal pressure. 
3.2.4 Decrease of cellular energy output 
Hypothermia blocks the production of energy at various levels, with cold-resistant 
enzymatic reactions remaining active, and with a limited supply of glycolytic intermediates 
and energetic reserves necessary for the maintenance of cellular integrity. These reactions 
stimulate synthesis of triglycerides from glucose. 
The main source of energy in the renal cortex during hypothermia is the metabolism of free 
fatty acids. The octanoic acids (especially caprilic acid) are degraded to acetyl-coenzyme A 
and enter the Krebs cycle. In contrast, long-chain free fatty acids, such as palmitic and 
miristic acids, cannot be degraded in energy-producing cycles but are incorporated to tissue 
triglycerides through an energy-consuming process. Furthermore, phosphorylation is 
suppressed during hypothermia due to the inability of adenosine diphosphate to penetrate 
the mitochondrial inner membrane after hypothermic inactivation of adenosine diphosphate 
translocase. The adenosine diphosphate stays in the cytosol and degrades to adenosine 
monophosphate, and finally to hypoxanthine, which easily diffuses outside of the cell. 
Recovery of the depleted adenosine diphosphate occurs through de novo synthesis, and 
could require several hours after reestablishment of normal temperatures and appropriate 
oxygen levels. Thus, the preservation solution needs to contain substances that will maintain 
or replenish ATP (for example adenosine and glutamate). 
3.2.5 Intracellular accumulation of calcium 
The calcium-calmodulin complex plays a central role in the regulation of multiple 
enzymes responsible for mitochondrial respiration, adenosine triphosphate transport and 
regulation of the ion transport and membrane potentials. These effects increase the 
chances that the control of cytosolic calcium could help restore or preserve the enzymatic 
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reactions necessary to maintain the integrity of cells subjected to hypothermic ischemia. 
Some calcium-mediated cellular reactions require maintenance of low levels of cytosolic 
calcium, together with an ability to rapidly fluctuate these levels along large ranges of 
concentration, in such a way that specific intracellular targets can be alternatively 
activated and deactivated. 
During hypothermic ischemia, the enzymatic systems primarily responsible for calcium 
efflux are deactivated at the plasma membrane (calcium-specific adenosine triphosphatase 
and calcium-sodium exchange system). The rapid depletion of the energy reserves during 
hypothermic ischemia results in deactivation of calcium-specific adenosine-triphosphatase, 
which causes a massive influx of sodium into the cytosol; as a consequence, there is failure 
of the calcium-sodium exchange system. There is also a massive influx of calcium, which 
adversely affects numerous cellular enzymes, producing deterioration of cellular function 
and eventually cellular death. 
The changes in the calcium-calmodulin complex can also generate mitochondrial and 
membrane dysfunction, damaging the phospholipid nature of these structures by activating 
the phospholipase pathway with subsequent production of prostaglandin derivatives. This 
damage primarily affects endothelial cells, and is observed prior to the damage to the 
parenchymal cells. Endothelial separation, due to cytoskeletal damage, could result in 
collagen exposure, which in turn produces platelet aggregation and intravascular 
coagulation. Although an organ in which the parenchymal cells have been damaged can be 
recovered, this is not feasible when the damage affects the endothelial cells. 
4. Pathophysiology of renal allograft reperfusion upon implantation 
Much of the injury to transplanted kidneys does not occur during ischemia, but instead 
during reperfusion at the time of implantation. This damage is a consequence of the 
following events: 
4.1 Release of accumulated toxic metabolites 
Re-establishment of blood flow allows the recovery of the oxygen supply and the 
elimination of accumulated toxic metabolites. Although reperfusion is necessary to recover 
the organ after the ischemic injury, the systemic release of these toxic metabolites into 
circulation could have metabolic consequences in distant sites, as well as produce local 
tissue damage. Additionally, some of these events can trigger inflammatory processes which 
are a direct stimulus to the immune system, significantly contributing to the risk of acute 
graft rejection. 
4.2 Reactive oxygen species 
Damage due to free radicals is less significant in the kidneys than other organs. The greatest 
source of oxygen radicals comes from the activation of the enzyme xanthine oxidase, 
although leukocyte and macrophage activation can also be involved. The end products of 
the degradation of ATP are frequently metabolized to urea by the action of xanthine 
dehydrogenase. However, in an acidic environment, xanthine dehydrogenase becomes 
xanthine oxidase. When oxygen is supplied to the cellular environment during reperfusion,  
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xanthine oxidase converts accumulated extracellular waste into xanthine and superoxide 
anion (a reactive oxygen species). This anion rapidly reacts with itself to form hydrogen 
peroxide, a potent oxidizing agent capable of injuring the cell by oxidizing lipid membranes 
and cellular proteins. Hydrogen peroxide also triggers the production of other potent 
reactive oxygen species, including hydroxyl radical and singlet oxygen. Finally, these events 
lead to alteration of mitochondrial respiration and to lipid peroxidation with subsequent 
cellular destruction. The production of reactive oxygen species also initiates production of 
prostaglandins (by direct activation of phospholipase), including Leukotriene B4 and 
Platelet Activating Factor. These substances increase leukocyte adhesion to the vascular 
endothelium. Neutrophils could contribute to local injury by blocking microcirculation and 
by degranulation, which results in proteolytic damage to the kidney. It is therefore advisable 
to add substances to the preservation solution that protect against the formation of reactive 
oxygen species (for example, allopurinol), or “radical cleansers” (superoxide dismutase, iron 
chelating agents, mannitol, dimethylnitrosamine). However, it should be noted that the 
potential benefits of these components are the subject of debate. 
4.3 Release of cytokines 
Ischemia-reperfusion is associated with strong release of Tumor Necrosis Factor alpha, 
Interferon gamma, Interleukin 1 and Interleukin 8. These cytokines cause an up-regulation 
of adhesive molecules which produce leukocyte adherence and platelet plugs after 
revascularization, resulting in graft failure and kidney rejection. 
The vascular endothelium modulates smooth muscle tone in the vessel by releasing various 
local hormones or autacoids. The production of one of them, nitric oxide, which is induced 
by inflammatory cytokines, correlates with acute rejection. 
5. Available preservation solutions 
For kidney preservation by cold storage, the Euro-Collins (EC) solution, University of 
Wisconsin (UW) solution, Histidine-Tryptophan-Ketoglutarate (HTK) solution, or Celsior 
solution can be used. The components are described in table 1. 
The UW solution seems to be associated with better results when compared to the EC 
solution, showing better initial graft function and a 10% reduction in the need for dialysis 
after transplantation (the mean need for dialysis with preservation by storage in cold is 
between 20 and 50%).  Both solutions guarantee preservation of up to 30 hours, so the 
kidney implantation surgery is completely elective (programmed). 
Continuous hypothermic perfusion reduces the incidence of initial graft failure (need for 
postransplant dialysis) to 10%. 
5.1 Euro-Collins solution 
This solution is nowadays used as a preservation solution in isolated renal explantation, 
yielding preservation times of up to 30 hours with less cost than UW solution. However, 
muticentric studies show a better initial graft function with less need for dialysis in grafts 
preserved in UW solution. 
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COMPONENT EC 
(mmol/l)
UW 
(mmol/l)
HTK 
(mmol/l)
Celsior 
(mmol/l) 
Function 
Sodium 10 30 15 100 Electrolyte 
Potassium 115 120 10 15 Electrolyte 
Magnesium - 5 4 13 Electrolyte y cytoprotector 
Chloride 15 - 50 - Electrolyte 
Calcium - - 0,015 0,25 Electrolyte 
Phosphate 50 25 - - Buffer 
Sulphate - 5 - - Buffer 
Bicarbonate 10 - - - Buffer 
Histidine - - 180 30 Buffer and waterproofing 
Histidine CIH - - 18 - Buffer 
Glucose 195 - - - Waterproofing 
Mannitol - - 30 60 Waterproofing 
Raffinose - 30 - - Waterproofing 
Lactobionate - 100 - 80 Waterproofing and 
chelating Fe and Ca 
Adenosine - 5 - - Energy 
Ketoglutarate - - 1 - Energy 
Glutamate - - - 20 Energy 
Glutathione - 3 - 3, reduction Anti-free radicals 
Allopurinol - 1 - - Anti-free radicals (inhibits 
xhantine-oxidase) 
Tryptophan - - 2 - Membrane stabilizer 
Dexamethasone - 8 - - Membrane stabilizer 
Insulin - 100 U/l - - Membrane stabilizer 
HES (Hydrox-Ethyl- 
Starch), a synthetic 
starch 
- 50 g/l - - Synthetic colloid 
pH 7 7,4 7,2 7,3  
Osmolarity 355 320 310 340  
Viscosity Low High Low Low  
Table 1. Preservation solutions and their components. EC=Euro-Collins, UW=Universtiy of 
Wisconsin, HTK= Histidine-Tryptophan-Ketoglutarate. 
5.2 Belzer or University of Wisconsin solution 
Currently, this is the solution used for preservation of all abdominal organs, including the 
kidneys. Basically, it is composed of lactobionate and raffinose as waterproofing agents, 
hydroxyl-ethyl-starch (colloid), phosphate (buffer), adenosine (precursor of ATP synthesis), 
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and glutathione and allopurinol (to counteract oxygen radicals). It does not contain glucose 
and it is an “intracellular” solution (rich in potassium and low in sodium), similar to the EC 
solution. 
The disadvantages of UW are the following: 
1. High cost 
2. It has to be kept refrigerated until its use. 
3. Supplements need to be added immediately before its use (insulin, penicillin and 
dexamethasone), although this can be excluded without adverse effects. 
4. The glutathione losses efficacy with time (unstable). 
5. The solution can precipitate, requiring filtering during kidney perfusion and rinsing. 
5.3 HTK-bretschneider (Custodiol) 
It is named HTK because of its components (Hisitidine-Tryptophan-Ketoglutarate) It is an 
“extracellular solution” (low in potassium) and its components include histidine (buffer and 
osmotic effect), mannitol (waterproofing agent, osmotic effect and anti-reactive oxygen 
species), tryptophan (membrane stabilizer) and ketoglutarate (substrate for cellular 
metabolism). Its osmolarity is similar to that of the UW solution (310 vs. 320) and has a 
lower osmotic pressure (15-25 mmHg vs. 0 mmHg). It has lower viscosity, which is why a 
smaller volume of solution is used during perfusion.  
Regarding cost, HKT is comparable to the UW solution, when the specific requirements for 
the use of either solution are taken into account. HKT remains stable at room temperature, 
so it does not need to be refrigerated (unlike UW, although cooling to 4°C should be 
performed at least 2 to 3 hours before its use). HKT also does not precipitate and does not 
require filtering during perfusion. Being a low potassium solution, HKT also has the 
(theoretical) advantage of minimizing vascular injury. 
5.4 Celsior 
This is an “extracellular solution” (low in potassium). Its composition includes 
waterproofing agents like lactobionate and mannitol, antioxidants like reduced glutathione, 
metabolic substrates like glutamate, and a buffer (histidine). The solution is stable, it does 
not need refrigeration or filtering during perfusion. The volume needed to perfuse and its 
cost are similar to those of the UW solution. 
6. Conclusions 
Despite evidence that preservation techniques with perfusion machines provide better graft 
quality and longer periods of preservation, perfusion and subsequent storage at 4°C (for the 
shortest period possible) is still the standard procedure for preservation of renal grafts. A 
valid argument in favor of this practice is that it provides acceptable results with a simpler 
and cheaper method than the use of perfusion machines, which requires expensive and 
cumbersome equipment, as well as additional personnel. An important limitation of the 
preservation of organs by storage in cold is the impossibility of assessing whether the organ 
will adequately function after implantation. In this sense, machine perfusion offers a series 
of added advantages with respect to the preservation by simple cooling: a) it reduces the 
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vascular resistance induced by ischemia and facilitates the elimination of erythrocyte 
remnants from the microcirculation, which allows better reperfusion after implantation, and 
b) it allows testing of the viability or quality of the organ before implantation, by monitoring 
the flow and pressure, or by determination of biochemical markers related to organ viability 
released into the preservation solution (alpha glutathione-S-transferase, pi-glutathione-S-
transferase, alanineaminopeptidase, among others). 
Preservation with HPM is routinely used in only few centers around the world. In Europe 
its use is not extensive, but in the United States it is used in about 20% of kidney transplant 
centers. 
The most frequently used preservation fluids are Euro-Collins, University of Wisconsin and 
HTK-Custodiol, which yield preservation times between 18 and 36 hours. 
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